Fractional ablative CO 2 laser and oral isotretinoin—A prospective randomized controlled split‐face trial comparing concurrent versus delayed laser treatment for acne scars
Lasers in Surgery and Medicine · 2024
DOI: 10.1002/lsm.23713 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Surgery and Medicine, 2024. Verfasst von Eyal Taleb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Acne Vulgaris, Lasers, Gas. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Therapeutic dogma has been to treat acne scars with ablative fractional laser no less than 6 months after isotretinoin (ITN) cessation.
Objective
To evaluate the safety and efficacy of fractional ablative CO 2 laser (FACL) in patients treated concurrently with ITN.
Methods
We conducted a prospective split‐face randomized control trial in patients treated with FACL concurrently with ITN versus patients treated with FACL 6 months post‐ITN treatment. Patients received 3 monthly sessions of FACL with concurrent ITN treatment on half of the face; the other side of the face received the same FACL treatment regimen 6 months post‐ITN cessation. Patients were followed for adverse effects up to 6 months post‐FACL treatment. Final cosmesis was scored using the Quantitative Global Acne Scarring Grading System (GASGS) by three independent dermatologists.
Results
The GASGS of the concurrent ITN‐FACL treated side of the face was significantly lower than the side treated with delayed laser therapy (4.7 ± 2.5 vs. 7.7 ± 2.9, respectively, p < 0.001).
Limitations
The laser's settings were standardized, and not adjusted per patient skin type.
Conclusion
Per our prospective trial, concurrent treatment of FACL ‐ITN is superior to delayed FACL treatment 6 months post‐ITN cessation. Fractional ablative laser treatment is effective in improving acne scars, which persist despite isotretinoin therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Elisa S Gallo, Amir Koren
Zitieren
APA
Taleb, E., Gallo, E. S., Salameh, F., Koren, A., Shehadeh, W., & Artzi, O. (2024). Fractional ablative CO 2 laser and oral isotretinoin—A prospective randomized controlled split‐face trial comparing concurrent versus delayed laser treatment for acne scars. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23713
Vancouver
Taleb E, Gallo ES, Salameh F, Koren A, Shehadeh W, Artzi O. Fractional ablative CO 2 laser and oral isotretinoin—A prospective randomized controlled split‐face trial comparing concurrent versus delayed laser treatment for acne scars. Lasers in Surgery and Medicine. 2024. doi:10.1002/lsm.23713
BibTeX
@article{Taleb2024,
author = {Taleb, Eyal and Gallo, Elisa S and Salameh, Fares and Koren, Amir and Shehadeh, Waseem and Artzi, Ofir},
title = {Fractional ablative CO 2 laser and oral isotretinoin—A prospective randomized controlled split‐face trial comparing concurrent versus delayed laser treatment for acne scars},
journal = {Lasers in Surgery and Medicine},
year = {2024},
doi = {10.1002/lsm.23713}
}
EUVIMED